Research ArticleClinical Studies

Blood Parameters Demonstrating a Significant Survival Impact in Patients With Locally Advanced NSCLC Undergoing Definitive Chemoradiotherapy

MICHAEL HOFFMANN, DANIEL REITZ, JULIAN TAUGNER, OLARN ROENGVORAPHOJ, LUKAS KÄSMANN, CHUKWUKA EZE, MONIKA KARIN, CLAUS BELKA and FARKHAD MANAPOV
Anticancer Research April 2020, 40 (4) 2319-2322; DOI: https://doi.org/10.21873/anticanres.14198

Article Information

vol. 40 no. 4 2319-2322
DOI 
https://doi.org/10.21873/anticanres.14198
PMID 
32234932
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received February 8, 2020
  • Revision received February 25, 2020
  • Accepted February 27, 2020
  • Published online March 31, 2020.
Copyright & Usage 
Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. MICHAEL HOFFMANN1,*⇑,
  2. DANIEL REITZ1,*,
  3. JULIAN TAUGNER1,
  4. OLARN ROENGVORAPHOJ1,
  5. LUKAS KÄSMANN1,2,3,
  6. CHUKWUKA EZE1,
  7. MONIKA KARIN1,
  8. CLAUS BELKA1,2,3 and
  9. FARKHAD MANAPOV1,2,3
  1. 1Department of Radiotherapy and Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
  2. 2Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL), Munich, Germany
  3. 3German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany
  1. Correspondence to: Michael Hoffmann, Department of Radiotherapy and Radiation Oncology, Ludwig-Maximilians-Universität, Marchioninistraße 15, 81377 München, Germany. Tel: +49 89440073770, Fax: +49 89440076770, e-mail: Michael.hoffmann{at}med.uni-muenchen.de
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Blood Parameters Demonstrating a Significant Survival Impact in Patients With Locally Advanced NSCLC Undergoing Definitive Chemoradiotherapy
MICHAEL HOFFMANN, DANIEL REITZ, JULIAN TAUGNER, OLARN ROENGVORAPHOJ, LUKAS KÄSMANN, CHUKWUKA EZE, MONIKA KARIN, CLAUS BELKA, FARKHAD MANAPOV
Anticancer Research Apr 2020, 40 (4) 2319-2322; DOI: 10.21873/anticanres.14198
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords